title: Could irbesartan trigger autoimmune cholestatic hepatitis?
authors.forename: Brigida E
authors.initials: BE
authors.lastname: Annicchiarico
authors.forename: Massimo
authors.initials: M
authors.lastname: Siciliano
mesh_terms: D000368:Aged; D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001713:Biphenyl Compounds / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology*; D002780:Cholestasis, Intrahepatic / Q000139:chemically induced; D019693:Hepatitis, Autoimmune / Q000209:etiology*; D006801:Humans; D000077405:Irbesartan; D008297:Male; D013777:Tetrazoles / Q000009:adverse effects*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D013777:Tetrazoles; D000077405:Irbesartan